PHUSE De-identification Standards

Created by Wendy Dobson, last modified on Oct 30, 2020

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

There are current efforts by regulators such as the EMA to make Clinical Study Reports (CSRs) and Individual Patient Data (IPD) from clinical trials shared more widely. The PHUSE De-identification Standards Working Group has worked on defining de-identification standards for CDISC SDTM 3.2 and has recently reviewed the Health Canada Guidance document. The team will extend its scope to other CDISC standards in the future.

Project Leads:

Beate Hientzsch - beate.hientzsch@mainanalytics.de

No labels